Toshio Watanabe

7PUBLICATIONS
7CO-AUTHORS
Molecular targetsNutritional epidemiologyRheumatology and arthritisImmunogenetics (incl. genetic immunology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 18, 2022
Pirfenidone prevents esophageal stricture by inhibiting nucleotide binding oligomerization domain like receptor protein 3 inflammasome activation.

Shinji Hirano, Akira Higashimori, Yasuaki Nagami

|May 19, 2021
Reply to the letter by Ouyang et al. regarding our manuscript "Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer".

Toshio Watanabe, Yuji Nadatani, Yasuhiro Fujiwara

|Feb 08, 2021
Prevalence and risk factors of functional constipation in the Rome IV criteria during a medical check-up in Japan.

Koji Otani, Toshio Watanabe, Kanae Takahashi

|Nov 17, 2020
Long-term persistence of gastric dysbiosis after eradication of Helicobacter pylori in patients who underwent endoscopic submucosal dissection for early gastric cancer.

Toshio Watanabe, Yuji Nadatani, Wataru Suda

|Sep 12, 2020
Role of nucleotide binding oligomerization domain-like receptor protein 3 inflammasome in stress-induced gastric injury.

Akira Higashimori, Toshio Watanabe, Yuji Nadatani

|Dec 23, 2019
Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review.

Toshio Watanabe, Yasuhiro Fujiwara, Francis K L Chan

Pageof 2